Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

UFS graduates encouraged to continue their legacy
2016-04-25

Description: Autumn graduation 2016 Tags: Autumn graduation 2016

A total of 3681 qualifications, from seven different faculties, were conferred between 12 to 15 April 2016 at the University of the Free State Autumn Graduations on the Bloemfontein Campus.
Photo: Evert Kleynhans

Photo Gallery
Graduation Video Clip 

“You cannot let your legacy stop here. Use your qualifications to change the life of others.”

This was the call from Dr Muavia Gallie, a guest speaker at one of the Autumn Graduations on the Bloemfontein Campus of the University of the Free State (UFS). He is a School-Turnaround strategist and educational activist.

He was the speaker on 12 April 2016 at the Faculty of Education graduation ceremony in the Callie Human Centre. According to Dr Gallie and other speakers at the graduations, graduates need to use their qualifications for the good of South Africa.

A diverse group of graduates

A total of 3681 qualifications were conferred in seven faculties between 12 and 15 April 2016, the week of ceremonies comprising eight sessions. It was four days of festivities with friends and families gathering to celebrate with graduates.

The large number of graduates consisted of a diverse group. According to Dr Khotso Mokhele, Chancellor of the UFS, the group passing with distinctions was also much more diverse than in past years, especially in the number of female students.

Prof Jonathan Jansen, Vice-Chancellor and Rector of the UFS, said graduation ceremonies remain the most special days on the UFS calendar.

A total of 22 students from the Center for Universal Access and Disability Support also graduated during the week.

Work for next generation

Sello Hatang, the speaker on 12 April 2016 at the Faculties of Health Sciences, Law, and Theology ceremony, echoed Dr Gallie’s sentiments; “As you leave this university, your work begins for the next generation; to serve the people you care about in any way possible,” said Hatang, the Chief Executive of the Nelson Mandela Foundation.

Other speakers included Dawie Roodt, the most referenced economist in the media in 2015, at the ceremony of the Faculty of Economic and Management Sciences on 14 April 2016. The speaker on 15 April 2016 at the ceremony of the Faculty of Humanities was Nikiwe Bikitsha, one of South Africa’s leading journalists and broadcasters.

Achievers

In the Faculty of Natural and Agricultural Sciences, Madri Brink (Baccalaureus Scientiae Agriculture) received a Senate Medal for the best four-year Baccalaureus degree, while Kyla Hayter (Baccalaureus Scientiae Honores) won the Senate Medal for the best Honours student at the UFS. Willem Carel Brink from the Faculty of Humanities received a Senate Medal for the best three-year Baccalaureus Degree.

Deans’ medals awarded by the UFS.

Also see videos of the respective guest speakers:
Dr Muavia Gallie
Sello Hatang
Dawie Roodt
Nikiwe Bikitsha

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept